Abstract Background It is essential to investigate cognitive deficits in multiple sclerosis (MS) to develop evidence-based cognitive rehabilitation strategies. Here we refined cognitive decline assessment using the automated tests of the Cambridge Neuropsychological Test Automated Battery (CANTAB) and hierarchical cluster analysis. Methods We searched for groups of distinct cognitive profiles in 35 relapsing-remitting MS outpatients and 32 healthy controls. All individuals participated in an automated assessment (CANTAB) and in a pencil and paper general neuropsychological evaluation. Results Hierarchical cluster analysis of the CANTAB results revealed two distinct groups of patients based mainly on the Simple Reaction Time (RTI) and on the...
Background: Cognitive dysfunction appears all through the course of multiple sclerosis (MS). Mild an...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Abstract Background About 40–70% of patients with multiple sclerosis (MS) develop cognitive impairme...
Background: Cognition may be affected at least as seriously as physical function during multiple scl...
Cognitive dysfunction is present in up to 70% of patients with multiple sclerosis (MS) and has been ...
Background: Cognitive impairment affects half of the multiple sclerosis (MS) patient population and ...
The purpose of the study was to identify changes in cognitive abilities that affect patients with re...
Background: Cognitive impairment occurs in multiple sclerosis (MS) and undergoes a progressive worse...
Objective: In this longitudinal study, we monitored two large groups of multiple sclerosis (MS) pati...
Cognitive impairment (CI) frequently occurs in multiple sclerosis (MS) and is assumed to increase ov...
Objective: In this longitudinal study, we monitored two large groups of multiple sclerosis (MS) pati...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Neuropsychological assessment of cognitive functions in multiple sclerosis (MS) is increasingly cons...
Detecting cognitive dysfunction may be clinically important during the early stages of multiple scle...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Background: Cognitive dysfunction appears all through the course of multiple sclerosis (MS). Mild an...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Abstract Background About 40–70% of patients with multiple sclerosis (MS) develop cognitive impairme...
Background: Cognition may be affected at least as seriously as physical function during multiple scl...
Cognitive dysfunction is present in up to 70% of patients with multiple sclerosis (MS) and has been ...
Background: Cognitive impairment affects half of the multiple sclerosis (MS) patient population and ...
The purpose of the study was to identify changes in cognitive abilities that affect patients with re...
Background: Cognitive impairment occurs in multiple sclerosis (MS) and undergoes a progressive worse...
Objective: In this longitudinal study, we monitored two large groups of multiple sclerosis (MS) pati...
Cognitive impairment (CI) frequently occurs in multiple sclerosis (MS) and is assumed to increase ov...
Objective: In this longitudinal study, we monitored two large groups of multiple sclerosis (MS) pati...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Neuropsychological assessment of cognitive functions in multiple sclerosis (MS) is increasingly cons...
Detecting cognitive dysfunction may be clinically important during the early stages of multiple scle...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Background: Cognitive dysfunction appears all through the course of multiple sclerosis (MS). Mild an...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Abstract Background About 40–70% of patients with multiple sclerosis (MS) develop cognitive impairme...